Eli Lilly and Company (NYSE:LLY) announced a partnership with Rznomics to develop RNA-based gene therapies for sensorineural ...

Unlike the Get Better campaign — which was built throughout last year — Seeking launched with a full body of creative work, ...

Eli Lilly has spent the last several years reintroducing itself to the public via a series of corporate campaigns. | Eli Lilly has spent the last several years reintroducing itself to the public via a ...

Carencro Bob Lilly Elementary has received a Laura Bush Foundation grant to expand and update its school library.

Carencro Bob Lilly Elementary School has been selected as a recipient of the prestigious Laura Bush Foundation for America’s ...

Eli Lilly & Co.’s stock soared 14% Thursday, to put it on track for its biggest one-day gain in about 25 years, after the drugmaker reported positive results from a late-stage trial of a GLP-1 ...

Eli Lilly and Co. and Purdue University announce a $250 million investment to continue to accelerate pharmaceutical ...

Purdue University has announced a series of new degrees, a synergistic faculty recruitment initiative in the advanced ...

Fawn Weaver, co-founder of Uncle Nearest Whiskey, encouraged FAMU graduates to defy limitations in her commencement speech.

Eli Lilly (NYSE: NYSE:LLY) is set to report its first-quarter earnings on Thursday, May 1st, before the market opens. Analysts expect the drugmaker to earn $3.46 (+34.1% Y/Y) on revenue of $12.72B ...

Growth stocks often don't come cheap, especially when their prospects look great, as is the case with Eli Lilly (NYSE: LLY). It is the most valuable healthcare company in the world, with a market ...

Positive results for Eli Lilly's new diabetes and weight-loss drug have recently boosted its stock price. Data from several studies on the GLP-1 drug are expected to come out this year.